» Articles » PMID: 34022101

Ca Mishandling in Heart Failure: Potential Targets

Overview
Specialty Physiology
Date 2021 May 22
PMID 34022101
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Ca mishandling is a common feature in several cardiovascular diseases such as heart failure (HF). In many cases, impairment of key players in intracellular Ca homeostasis has been identified as the underlying mechanism of cardiac dysfunction and cardiac arrhythmias associated with HF. In this review, we summarize primary novel findings related to Ca mishandling in HF progression. HF research has increasingly focused on the identification of new targets and the contribution of their role in Ca handling to the progression of the disease. Recent research studies have identified potential targets in three major emerging areas implicated in regulation of Ca handling: the innate immune system, bone metabolism factors and post-translational modification of key proteins involved in regulation of Ca handling. Here, we describe their possible contributions to the progression of HF.

Citing Articles

Recombinant Klotho administration after myocardial infarction reduces ischaemic injury and arrhythmias by blocking intracellular calcium mishandling and CaMKII activation.

Vazquez-Sanchez S, Blasco A, Fernandez-Corredoira P, Cantolla P, Mercado-Garcia E, Rodriguez-Sanchez E J Pathol. 2025; 265(3):342-356.

PMID: 39815421 PMC: 11794962. DOI: 10.1002/path.6388.


Advancing 3D Engineered In Vitro Models for Heart Failure Research: Key Features and Considerations.

van Doorn E, Amesz J, Manintveld O, de Groot N, Essers J, Shin S Bioengineering (Basel). 2025; 11(12.

PMID: 39768038 PMC: 11673263. DOI: 10.3390/bioengineering11121220.


Utilization of the genetically encoded calcium indicator Salsa6F in cardiac applications.

Marquez-Nogueras K, Bovo E, Neczypor J, Cao Q, Zima A, Kuo I Cell Calcium. 2024; 119:102873.

PMID: 38537433 PMC: 11018326. DOI: 10.1016/j.ceca.2024.102873.


Ion channel trafficking implications in heart failure.

Reisqs J, Qu Y, Boutjdir M Front Cardiovasc Med. 2024; 11:1351496.

PMID: 38420267 PMC: 10899472. DOI: 10.3389/fcvm.2024.1351496.


Inhibition of adenylyl cyclase 8 prevents the upregulation of Orai1 channel, which improves cardiac function after myocardial infarction.

Falcon D, Calderon-Sanchez E, Mayoral-Gonzalez I, Martin-Bornez M, Dominguez-Rodriguez A, Gutierrez-Carretero E Mol Ther. 2024; 32(3):646-662.

PMID: 38291755 PMC: 10928147. DOI: 10.1016/j.ymthe.2024.01.026.